featured
The Role of Percentage of Prostate-Specific Antigen Reduction After Focal Therapy for Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Urology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Role of Percentage of Prostate-Specific Antigen Reduction After Focal Therapy Using High-Intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results From a Large Multi-Institutional Series
Eur Urol 2020 Aug 01;78(2)155-160, A Stabile, C Orczyk, F Giganti, M Moschini, C Allen, S Punwani, N Cathala, HU Ahmed, X Cathelineau, F Montorsi, M Emberton, A Briganti, R Sanchez-Salas, CM MooreFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.